|4Apr 29, 4:19 PM ET

Harvey Jimmie 4

4 · Fortress Biotech, Inc. · Filed Apr 29, 2022

Insider Transaction Report

Form 4
Period: 2022-01-01
Transactions
  • Award

    COMMON STOCK, PAR VALUE $0.001

    2022-01-01+100,000850,000 total
Footnotes (2)
  • [F1]One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer.
  • [F2]The total holdings include 800,000 shares of deferred restricted stock.

Documents

1 file
  • 4
    tm2213913-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT